drugset / Trial / NCT02507050

Ivabradine and Post-revascularisation Microcirculatory Dysfunction

NCT02507050

RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the study is to test whether, in patients with angina and flow limiting epicardial coronary artery disease, pre-treatment with Ivabradine, as opposed to beta blockers, will reduce post percutaneous coronary intervention induced microvascular dysfunction.

Timeline

Start
2016-03
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ivabradine Small molecule 7.5 mg